| Hsu CS, Kao JH
Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C. [Comment, Letter]
N Engl J Med 2009 Oct 29; 361(18):1808-9; author reply 1809.
Full Citation | Find Related Articles |
| Breilh D, Djabarouti S, Trimoulet P, et al.
Ribavirin Plasma Concentration Predicts Sustained Virological Response to Peginterferon Alfa 2a Plus Ribavirin in Previously Treated HCV-HIV-Coinfected Patients. [JOURNAL ARTICLE]
J Acquir Immune Defic Syndr 2009 Nov; 52(3):428-430.
Full Citation | Find Related Articles |
| Tiesmeier J, Dienes HP, Schuppert F
[Elevation of liver enzymes in a patient with chronic hepatitis B during alpha-interferon treatment: what is it all about?] [Journal Article]
MMW Fortschr Med 2009 Sep 10; 151(37):48-50.
Full Citation | Find Related Articles |
| Barakat FM, McDonald V, Foster GR, et al.
Cryptosporidium parvum infection rapidly induces a protective innate immune response involving type I interferon. [Journal Article, Research Support, Non-U.S. Gov't]
J Infect Dis 2009 Nov 15; 200(10):1548-55.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Ji J, Shi J, Budhu A, et al.
MicroRNA expression, survival, and response to interferon in liver cancer. [Journal Article, Research Support, N.I.H., Intramural]
N Engl J Med 2009 Oct 8; 361(15):1437-47.
Abstract | Full Citation | Find Related Articles |
| Ku JY, Sharma A
Pegylated interferon and ribavirin therapy for hepatitis C causing cataract. [Letter]
Clin Experiment Ophthalmol 2009 Sep; 37(7):743-5.
Full Citation | Publisher Full Text | Find Related Articles |
| Antonicelli L, Stagnozzi G, Giuliodoro S, et al.
The safety of omalizumab therapy in a patient with severe persistent allergic asthma and hepatitis C. [Letter]
Ann Allergy Asthma Immunol 2009 Sep; 103(3):269-70.
Full Citation | Find Related Articles |
| Corey KE, Kane E, Munroe C, et al.
Hepatitis C virus infection and its clearance alter circulating lipids: Implications for long-term follow-up. [JOURNAL ARTICLE]
Hepatology 2009 Aug 10; 50(4):1030-1037.
Abstract | Full Citation |
| Nelson DR
Hepatitis C drug development at a crossroads. [JOURNAL ARTICLE]
Hepatology 2009 Aug 5; 50(4):997-999.
Full Citation | Find Related Articles |
| Wieczorek M, Litwińska B
[The influence of Namalwa cells on inhibition of HSV-1 replication] [English Abstract, Journal Article]
Med Dosw Mikrobiol 2009; 61(2):197-202.
Abstract | Full Citation | Find Related Articles |
  |
